Expensing Stock Options: The Role of Publicity

41 Pages Posted: 5 Nov 2003

See all articles by Chandra Seethamraju

Chandra Seethamraju

Franklin Templeton Investments

Tzachi Zach

Ohio State University (OSU) - Department of Accounting & Management Information Systems

Date Written: October 2003

Abstract

In this paper we offer explanations for why firms began voluntarily adopting the expensing provisions of FAS 123 in the second half of 2002. First, we find that firms with greater publicity exposure are more likely to voluntarily expense stock options, controlling for other factors such as the magnitude of the stock option expense. This publicity incentive also explains the timing of the decisions, the summer of 2002, immediately following the accounting scandals of Enron and WorldCom. Second, we find that valuation benefits from expensing stock options, proxied by market's reaction to the proposition by the FASB to undertake a project requiring firms' to expense stock options, are positively associated with the decision to expense. Third, we do not find evidence that stronger corporate governance is associated with the likelihood to expense options. Finally, we find some evidence suggesting that, compared to control firms, expensing firms reduce the number of options granted in 2002 and have started to make more changes to their compensation plans as reflected in the most recent proxy statements.

Keywords: stock options expensing, publicity

JEL Classification: M41, M44, G12, G34, J33

Suggested Citation

Seethamraju, Chandrakanth and Zach, Tzachi, Expensing Stock Options: The Role of Publicity (October 2003). Available at SSRN: https://ssrn.com/abstract=461760 or http://dx.doi.org/10.2139/ssrn.461760

Chandrakanth Seethamraju

Franklin Templeton Investments ( email )

Multi Asset Strategies
P.O. Box 997152
San Mateo, CA 95899-7152
United States

Tzachi Zach (Contact Author)

Ohio State University (OSU) - Department of Accounting & Management Information Systems ( email )

2100 Neil Avenue
Columbus, OH 43210
United States
614-292-4101 (Phone)

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
696
Abstract Views
5,095
Rank
68,651
PlumX Metrics